# Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer

> **NCT00299286** · PHASE2 · COMPLETED · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 121 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Lapatinib
- **DRUG:** Lapatinib-Placebo

## Key facts

- **NCT ID:** NCT00299286
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2012-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00299286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00299286, "Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00299286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*